PINK1 and Parkinson disease: Thus, the establishment of non-human primate models of PINK1-Parkin-associated PD that reproduce PD-like phenotypes and the evaluation of drug properties including pharmacokinetic profiles and potential adverse effects using these mammalian models are required in the future studies.